Research & Innovation
Publications
Rigosertib demonstrates considerable efficacy and safety in the treatment of advanced/metastatic cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa
PMU Authors
M. Laimer, E. Mayr, J. Bauer
All Authors
M. Laimer, A. South, H. Y. Yang, L. Banner, E. Mayr, S. Kitzmueller, M. Parris, M. Arora, J. Bauer, N. Nikbakht
Journal association
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Abstract
We are sorry. The full text is not available.